Mother’s own milk, hailed as nature’s perfect biofluid for newborns, is a dynamic, living system tailored intricately to meet the nutritional and immunological needs of the infant. Underscoring the complexity, this milk contains an array of bioactive components such as live immune cells, hormones, growth factors, enzymes, and an evolving microbiome that adapts over time. In contrast, pasteurized donor milk, typically sourced from healthy lactating women and subjected to Holder pasteurization, loses many of these delicate constituents, raising concerns about its ability to fully replicate the protective and developmental benefits of a mother’s own milk.

Holder pasteurization—a heat treatment involving warming donor milk to 62.5°C for 30 minutes—effectively inactivates pathogenic microorganisms, ensuring safety for vulnerable preterm infants. Yet, this process also denatures vital proteins like lactoferrin and immunoglobulins, diminishes enzyme activity such as bile salt-stimulated lipase, and disrupts beneficial microbes and microbiota-derived metabolites. The review emphasizes that such alterations may influence gut microbial colonization and maturation, a critical determinant of gut barrier function and immune development in preterm neonates.

Preterm infants inherently face a precarious intestinal environment characterized by immaturity, increased permeability, and susceptibility to necrotizing enterocolitis (NEC), a devastating inflammatory condition of the bowel. The authors highlight that mother’s own milk robustly supports gut integrity through bioactive components that promote epithelial growth, modulate inflammation, and foster beneficial microbial symbiosis. In contrast, donor milk’s diminished bioactivity may attenuate these protective mechanisms, potentially impacting intestinal barrier maturation and the infant’s immune resilience against NEC and sepsis.

The review delves into the role of human milk oligosaccharides (HMOs), complex sugars abundantly present in mother’s milk but variably altered by pasteurization. HMOs serve as prebiotics shaping neonatal gut microbiota by encouraging colonization by Bifidobacteria and other commensal microbes. These microbial populations coordinate immune signaling and metabolic functions vital for intestinal homeostasis. The extent to which pasteurization compromises HMO integrity or their functional capacity remains an area demanding deeper exploration, flagged by Sundararajan and Ma as crucial for refining donor milk processing techniques.

Beyond microbial and immunological aspects, the hormonal and growth factor milieu is dramatically different. Mother’s milk delivers epidermal growth factor (EGF), transforming growth factor-beta (TGF-β), and insulin-like growth factors (IGFs) that stimulate enterocyte proliferation and modulate immune tolerance. Pasteurized donor milk often shows reduced concentrations of these bioactive molecules, potentially influencing the timing and quality of intestinal maturation in premature infants. These changes underscore a biological “gap” between milk types that transcends mere nutrient content into sophisticated developmental programming.

The authors advocate for innovative intervention strategies aimed both at enhancing donor milk quality and supplementing bioactive deficits. This might involve alternative pasteurization methods like high-pressure processing, ultraviolet irradiation, or flash-heat treatments that better preserve milk’s functional components without compromising safety. Moreover, supplementation with purified bioactives, probiotics, or prebiotics represents a promising frontier to ameliorate the biological gap, supporting a more physiological intestinal environment in preterm neonates.

Given the vulnerable state of preterm infants whose gut microbiome is continually evolving, the review further details how pasteurized donor milk’s impact on microbial diversity and metabolic capacity could affect systemic immune training. Studies referenced demonstrate that donor milk-fed infants often showcase delayed colonization by beneficial bacteria and altered metabolomic profiles, correlating with increased inflammation and potentially impaired neurodevelopmental trajectories later in life. These findings emphasize a pressing need to reconsider donor milk processing and neonatal nutrition protocols in NICUs globally.

Interestingly, Sundararajan and Ma also point to growing evidence of epigenetic influences mediated by human milk components. Epigenetic programming during this critical window shapes gene expression patterns, influencing immunity, metabolism, and disease susceptibility in adulthood. The biological gap between mother’s own milk and pasteurized donor milk may thus extend to epigenomic consequences, an insight that opens new research avenues on long-term infant health beyond neonatal survival rates.

Ethical and practical considerations surrounding milk banking and the equitable distribution of high-quality human milk products are underscored in the review. The authors call for multidisciplinary collaboration among neonatologists, biochemists, nutritionists, and policymakers to develop standards that minimize biological disparities, enhance milk safety, and consider the individualized needs of preterm infants. This systemic approach could revolutionize clinical practice and milk banking paradigms worldwide.

Moreover, this review reinforces an urgent call to elevate maternal lactation support and optimize collection methods to increase the availability of mother’s own milk in NICUs. Enhanced maternal nutrition, lactation counseling, and early milk expression techniques may reduce dependency on donor milk, ensuring more infants receive the tailored benefits of their own mother’s biological fluid. Supporting the mother-infant dyad remains a cornerstone of promoting intestinal health and promoting lifelong well-being in this fragile population.

In conclusion, the work of Sundararajan and Ma provides a compelling, multidimensional exploration of the biological chasm between mother’s own milk and pasteurized donor milk and its profound implications for intestinal health in preterm infants. As scientific innovation progresses, bridging this gap will be paramount to advancing neonatal care, mitigating complications, and fostering optimal development during the earliest, most vulnerable stage of life. The future of neonatal nutrition hinges on marrying safety with biological fidelity—ensuring that the life-giving properties of human milk are preserved in every drop fed to preterm infants.

Subject of Research:

Article Title:

Article References:

Sundararajan, S., Ma, B. Review of the biological gap between mother’s own milk and pasteurized donor milk: implications for intestinal health in preterm infants. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05025-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-026-05025-0

Human milk fortifiers are integral to neonatal intensive care, designed to augment the naturally occurring nutrients in breast milk to meet the heightened metabolic demands of preterm infants. However, to date, the compositional heterogeneity of these fortifiers, especially when derived from human milk itself, has been poorly characterized. The research conducted by Tarkleson et al. fills this critical void by meticulously analyzing the macronutrient profiles—proteins, lipids, and carbohydrates—as well as bioactive components, including immunomodulatory proteins and enzymes, across different HM-HMF concentration gradients.

One of the pivotal insights from the study is the clear evidence that the concentration of HM-HMF directly modulates the nutrient density of the milk. Increasing fortifier levels yields predictable upticks in protein and calorie content; however, the study reveals that these increments are not linear and may plateau or even diminish in bioactive component efficacy at higher fortification levels. Such non-linear relationships underscore the intricacy of human milk composition and suggest that simply increasing fortifier concentration does not necessarily translate into proportionate nutritional benefit.

Equally compelling is the differentiation between DHM procured from commercial milk banks versus non-profit milk banks. Commercial donor milk, often subject to industrial-scale processing and standardized pasteurization protocols, exhibited significantly altered macronutrient and bioactive profiles compared to non-profit bank milk, which typically undergoes more individualized screening and gentler handling procedures. Notably, commercial DHM samples contained lower concentrations of critical growth factors and immunological proteins, potentially attenuating their protective effects.

The comparative analysis extended to lipid profiles as well. Lipids, which constitute a major energy source and play an instrumental role in neurodevelopment, were found to be variably preserved in donor milk depending on the bank type. Non-profit bank milk retained higher levels of essential fatty acids, including docosahexaenoic acid (DHA) and arachidonic acid (ARA), which are crucial for cognitive development. The commercial DHM, by contrast, demonstrated diminished lipid variability and lower overall energy potential, possibly attributable to different collection, storage, and pasteurization methodologies.

Beyond macronutrients, bioactive molecules such as lactoferrin, lysozyme, and secretory immunoglobulin A (sIgA) showed marked disparities between commercial and non-profit milk sources. These molecules are instrumental in furnishing passive immunity and modulating the infant’s gut microbiome, facets critical for reducing infection risks in premature neonates. The reduction in these bioactive proteins in commercial donor milk raises significant concerns regarding its immunoprotective capacity and calls for a reevaluation of standard processing techniques.

The study also highlights the role of pasteurization methods in shaping milk composition. While both types of milk banks employed Holder pasteurization as a gold standard, subtle differences in procedural parameters led to varying degrees of protein denaturation and bioactive molecule degradation. Non-profit banks often employed stricter temperature control and minimized processing times, preserving a broader spectrum of functional proteins.

Importantly, this research underscores that the source and handling of donor milk are not merely logistical considerations but biomedical factors with direct consequences on infant health outcomes. The findings advocate for nuanced policies that prioritize milk processing protocols preserving bioactivity and nutritional integrity, potentially advocating for wider adoption of non-profit bank practices within commercial settings.

For clinicians, these revelations herald a pivotal shift in how neonatal nutrition protocols should be tailored. Reliance on bulk commercial DHM without accounting for its altered biochemical profile might undermine the therapeutic intentions of donor milk usage. A more stratified approach, possibly incorporating routine compositional assays and customized fortifier dosing, is essential to optimize nutritional interventions for the most vulnerable infants.

Additionally, the study opens avenues for further innovation in HM-HMF development. The recognition of non-linear metabolic effects challenges manufacturers to engineer fortifiers that not only boost macronutrient content but also preserve or enrich bioactive milieu. This might involve novel formulation techniques, gentle concentration methods, and perhaps even individualized fortification regimens guided by real-time milk analysis.

Neonatal nutrition researchers will find this work particularly seminal as it bridges the gap between compositional science and clinical application. The delineation of distinct biochemical phenotypes of donor milk derived from bank types sets a foundation for longitudinal studies linking milk intake profiles to neurodevelopmental and immunological outcomes in preterm cohorts.

Moreover, this study places a spotlight on ethical and economic dimensions. Non-profit milk banks, often operating under tighter resource constraints, appear to produce higher quality donor milk, emphasizing the need for equitable support and funding. Conversely, the dominant presence of commercial banks in the supply chain necessitates industry-wide commitments to transparency and quality assurance rooted in scientific evidence.

In conclusion, Tarkleson et al.’s work meticulously dissects the complex interplay of fortifier concentration and donor milk provenance in shaping the vital nutritional and immunological landscape of milk provided to preterm infants. It challenges assumptions, sparks critical discourse, and charts a course toward precision neonatal nutrition that honors both the art and science of human milk.

Subject of Research: Variation in macronutrient and bioactive composition of human milk-derived human milk fortifiers at different concentration levels, and comparison of donor human milk sourced from commercial versus non-profit milk banks.

Article Title: Macronutrient and bioactive profiles of donor milk differ in commercial vs non-profit milk banks.

Article References:
Tarkleson, T., Ackley, D., Cole, L. et al. Macronutrient and bioactive profiles of donor milk differ in commercial vs non-profit milk banks. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02679-w

Image Credits: AI Generated

DOI: 21 April 2026

Extremely preterm infants, defined as those born before 28 weeks of gestation, face enormous physiological challenges. Their underdeveloped organ systems, especially the brain, are exquisitely sensitive to nutritional input during the neonatal period. Historically, human milk has been accepted as the gold standard for infant nutrition due to its immunological and bioactive components. However, the nutrient composition of unfortified human milk may not suffice to meet the elevated demands of these infants, leading clinicians to explore fortification strategies, particularly protein supplementation, to enhance growth and neurodevelopmental outcomes.

The randomized controlled trial design employed by Jeffcoat and Salas allowed for a compelling comparison between two groups of extremely preterm infants: one receiving standard fortified human milk and the other receiving fortified human milk with an additional protein supplement. Over an extensive follow-up period, the researchers meticulously tracked growth parameters and embarked on thorough neurodevelopmental assessments, employing standardized cognitive and motor function tests. The data revealed a consistent pattern favoring the protein-enriched group, suggesting that increased protein intake during this critical window has lasting benefits well beyond hospital discharge.

From a biochemical perspective, protein is integral not only for somatic growth but also for the synthesis of neurotrophic factors and myelination processes essential for brain maturation. Jeffcoat and Salas leveraged these known mechanisms to contextualize their findings, hypothesizing that protein fortification supports heightened anabolism and facilitates neural connectivity essential for cognitive development. This hypothesis aligns with emerging insights from neonatal neurobiology that underscore how nutrition directly affects synaptic plasticity and white matter integrity in preterm infants.

Moreover, the study delved into growth velocity metrics, including weight, length, and head circumference, which are standard indicators linked directly to neurodevelopmental prognosis. Infants in the protein-supplemented cohort exhibited accelerated growth velocities without signs of metabolic overload or adverse renal outcomes, a crucial safety consideration given the immature renal function in preterm neonates. These findings provide a reassuring profile that intensified protein fortification is not only effective but also safe within the dosing parameters studied.

Technical analyses also incorporated the use of body composition assessment techniques, including air displacement plethysmography, providing a nuanced view of lean and fat mass accretion. The enriched protein group demonstrated a preferential increase in lean mass over adiposity, indicative of healthier growth patterns associated with improved future metabolic outcomes. This insight challenges the traditional view that faster weight gain in preterms necessarily correlates with increased fat deposition and potential long-term metabolic disease risk.

One particularly innovative aspect of the study was the investigation of neurodevelopmental milestones assessed at two years corrected age, a critical temporal juncture for determining the trajectory of cognitive, language, and motor skills. The protein-enriched group displayed statistically significant improvements on the Bayley Scales of Infant Development-III, particularly within the cognitive and motor composite scores. The methodological rigor in controlling for confounding variables such as socioeconomic factors, comorbidities, and parental education strengthens the validity of these neurodevelopmental findings.

Jeffcoat and Salas also contribute to the debate on nutritional strategies that optimize the balance between adequate nutrient provision and the risk of overfeeding. Their data support a tailored approach where protein supplementation is titrated to match individual growth and developmental needs rather than applied broadly and indiscriminately. This precision nutrition model represents a forward-thinking paradigm in neonatal care, combining the biological nuances of preterm infants with the emerging technologies enabling real-time growth monitoring.

Furthermore, the study ignites discussions on the potential for fortified milk with protein to mitigate the incidence of neurodevelopmental disabilities, including cognitive delays and motor impairments prevalent among extremely preterm infants. While recognizing that nutrition is one of many factors influencing neurodevelopment, the authors emphasize its modifiability compared to genetic or environmental determinants, positioning nutritional optimization as a frontline intervention for improving outcomes.

The implications of this study are far-reaching. Neonatal intensive care units worldwide could consider revising current feeding protocols to incorporate targeted protein supplementation in human milk. Such changes would necessitate updated clinical guidelines and ensure that the benefits observed in controlled trials translate into routine clinical practice, improving the quality of life for a growing population of extremely preterm survivors.

The complexity of human milk fortification extends beyond simple nutrient addition; it encompasses an understanding of the bioavailability of nutrients, synergistic effects between milk components, and the dynamic changes in milk composition during lactation. Jeffcoat and Salas’s work underscores the necessity for tailored fortification strategies that align with the evolving metabolic state of the preterm infant, rather than a one-size-fits-all approach.

Critically, this study utilized robust statistical methodologies to analyze longitudinal data, employing mixed-effects models to account for intra-subject variability and repeated measures. This analytical sophistication adds confidence to the interpretation of meaningful growth and developmental differences attributable to dietary intervention rather than random variation or measurement error.

One cannot overlook the translational potential of these findings. Future research may explore how protein-enriched human milk supplementation influences neuroplasticity at the molecular level, potentially integrating biomarkers such as myelination markers from advanced neuroimaging techniques. Such insights would further elucidate causal pathways linking nutrition to brain development, paving the way for novel therapeutic interventions alongside nutritional fortification.

Finally, the study appropriately calls for larger multi-center trials to validate these promising results across diverse populations, as well as explorations into the optimal timing, dosing, and composition of protein supplements. Such research will be essential to refine nutritional guidelines and ensure equity in outcomes among preterm infants from various socioeconomic and genetic backgrounds.

In summary, Jeffcoat and Salas have contributed a seminal study drawing a clear connection between enhanced protein intake via fortified human milk and improved long-term growth and neurodevelopment in extremely preterm infants. Their high-quality evidence emphasizes the need for a paradigm shift in neonatal nutrition, where precision and individualization, particularly concerning protein supplementation, serve as foundational principles for optimizing health and developmental trajectories in this fragile yet resilient population.

Subject of Research: Long-term growth and neurodevelopment of extremely preterm infants receiving fortified human milk diets enriched with protein supplements.

Article Title: Long-term growth and neurodevelopment of extremely preterm infants randomized to fortified human milk diets enriched with a protein supplement.

Article References:
Jeffcoat, S., Salas, A.A. Long-term growth and neurodevelopment of extremely preterm infants randomized to fortified human milk diets enriched with a protein supplement. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04354-w

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-025-04354-w